Consolidated Financial Statements >
CONSOLIDATED FINANCIAL STATEMENTS AND EXPLANATORY NOTES
240
| 2012 annual report prysmian group
22. AMORTISATION, DEPRECIATION AND IMPAIRMENT
23. OTHER EXPENSES
These are detailed as follows:
These are detailed as follows:
The Group incurred Euro 69 million in research and development costs in 2012 (Euro 68 million in 2011).
(in millions of Euro)
2012
2011
Depreciation of buildings, plant, machinery and equipment
124
114
Depreciation of other property, plant and equipment
5
3
Amortisation of intangible assets
35
25
Non-recurring impairment:
Impairment of property, plant and equipment
24
33
Impairment of intangible assets
-
5
Total non-recurring impairment
24
38
Total
188
180
(in millions of Euro)
2012
2011
Professional services
34
35
Insurance
41
35
Maintenance costs
83
72
Sales costs
87
66
Utilities
155
147
Travel costs
41
37
Vessel charter
67
73
Increases in provisions for risks
(8)
16
Sundry expenses
119
73
Other expenses
558
584
Non-recurring other expenses:
Draka acquisition costs
-
6
Effects of Draka change of control
-
2
Draka integration costs
9
12
Non-recurring other expenses
25
-
Tax inspections
3
-
Antitrust
1
205
Company reorganisation
10
17
Environmental remediation and other costs
3
5
Remeasurement of minority put option liability
-
1
Total non-recurring other expenses
51
248
Total
1,228
1,386
